[S,S]-Reboxetine Add-On Trial

Stopped early · Phase 2

Conditions studied: Pain

In brief

The purpose of this study is to determine the effectiveness of adjunctive treatment of pregabalin with \[S,S\]-Reboxetine against pregabalin monotherapy in patients with PHN

Key facts

Study ID

NCT00334685

Run by

Pfizer

People needed

136

Starts

2006-08-22

Expected to finish

2007-10-11

Last updated by the study team

2019-12-16

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients must have pain present for more than 3 months after the healing of shingles skin rash
• Patients at screening must have a score >/=40 mm on the pain visual analogue scale

You may not qualify if…

• Patients with significant renal and hepatic impairment
• Patients with other severe pain, that may impair the self-assessment of the pain due to shingles
• Patients with clinically abnormal electrocardiogram

Where it is running

• Pfizer Investigational Site — Gilbert, Arizona, United States
• Pfizer Investigational Site — North Dartmouth, Massachusetts, United States
• Pfizer Investigational Site — St Louis, Missouri, United States
• Pfizer Investigational Site — Amherst, New York, United States
• Pfizer Investigational Site — Orchard Park, New York, United States
• Pfizer Investigational Site — Kettering, Ohio, United States
• Pfizer Investigational Site — Vienna, Austria
• Pfizer Investigational Site — Calgary, Alberta, Canada
• Pfizer Investigational Site — Calgary, Alberta, Canada
• Pfizer Investigational Site — Edmonton, Alberta, Canada
• Pfizer Investigational Site — Kelowna, British Columbia, Canada
• Pfizer Investigational Site — Langley, British Columbia, Canada
• Pfizer Investigational Site — Greater Sudbury, Ontario, Canada
• Pfizer Investigational Site — Greater Sudbury, Ontario, Canada
• Pfizer Investigational Site — Hawkesbury, Ontario, Canada
• Pfizer Investigational Site — North Bay, Ontario, Canada
• Pfizer Investigational Site — Val Caron, Ontario, Canada
• Pfizer Investigational Site — Pointe-Claire, Quebec, Canada
• Pfizer Investigational Site — Québec, Quebec, Canada
• Pfizer Investigational Site — Saint Romuald, Quebec, Canada
• Pfizer Investigational Site — Regina, Saskatchewan, Canada
• Pfizer Investigational Site — Saskatoon, Saskatchewan, Canada
• Pfizer Investigational Site — Sasktatoon, Saskatchewan, Canada
• Pfizer Investigational Site — České Budějovice, Czechia
• Pfizer Investigational Site — Huntsville, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.